2023 - Research.com Medicine in Denmark Leader Award
His scientific interests lie mostly in Cancer research, Gene expression, Cancer, Bladder cancer and Internal medicine. His work deals with themes such as DNA methylation, Carcinogenesis, Cancer cell, Cell cycle and Gene silencing, which intersect with Cancer research. His Gene expression study results in a more complete grasp of Gene.
His research in Cancer tackles topics such as microRNA which are related to areas like DNA microarray. His Bladder cancer research also works with subjects such as
His primary areas of study are Internal medicine, Cancer research, Pathology, Bladder cancer and Cancer. His Internal medicine study combines topics in areas such as Endocrinology and Oncology. Torben F. Ørntoft has included themes like Methylation, Carcinogenesis, Cancer cell, microRNA and Gene silencing in his Cancer research study.
The concepts of his Pathology study are interwoven with issues in Urothelium, Gene expression and Antigen. His Bladder cancer study deals with Urine intersecting with Urology and Cystoscopy. His biological study spans a wide range of topics, including Stage and Immunology.
Torben F. Ørntoft focuses on Internal medicine, Oncology, Prostate cancer, Cancer and Bladder cancer. His Oncology research is multidisciplinary, relying on both Bioinformatics, Disease, Cohort, Pathology and microRNA. His study in the field of Biopsy also crosses realms of Cell-free fetal DNA.
His Cancer research incorporates elements of Mutation and Gene. His Bladder cancer research includes themes of Exome sequencing, Progressive disease, Cancer research and Metastasis. The various areas that he examines in his Cancer research study include Regulation of gene expression and Gene silencing.
Torben F. Ørntoft mainly investigates Bladder cancer, Internal medicine, Oncology, Disease and Cancer research. His studies in Bladder cancer integrate themes in fields like Mutation, Urine and Urology. His Oncology research is multidisciplinary, incorporating elements of Prostate cancer and Genetic association.
His Disease study is concerned with the field of Pathology as a whole. His Pathology study combines topics in areas such as Biomarker, Colorectal cancer and Digital polymerase chain reaction. He combines subjects such as Cancer, Bioinformatics, Transcriptome, microRNA and Gene silencing with his study of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets
Claus Lindbjerg Andersen;Jens Ledet Jensen;Torben Falck Ørntoft.
Cancer Research (2004)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Jirina Bartkova;Zuzana Horejsí;Karen Koed;Alwin Krämer.
Genome-wide association study identifies five new schizophrenia loci
Stephan Ripke;Alan R. Sanders;Kenneth S. Kendler;Douglas F. Levinson.
Nature Genetics (2011)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova;Nousin Rezaei;Michalis Liontos;Panagiotis Karakaidos.
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
Oliver M Sieber;Lara Lipton;Michael Crabtree;Karl Heinimann.
The New England Journal of Medicine (2003)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen;Mark Sausen;Vilmos Adleff;Alessandro Leal.
Science Translational Medicine (2017)
Identifying distinct classes of bladder carcinoma using microarrays
Lars Dyrskjøt;Thomas Thykjaer;Mogens Kruhøffer;Jens Ledet Jensen.
Nature Genetics (2003)
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Troels Schepeler;Jørgen T. Reinert;Marie S. Ostenfeld;Lise L. Christensen.
Cancer Research (2008)
Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
Lars Dyrskjøt;Mogens Kruhøffer;Thomas Thykjaer;Niels Marcussen.
Cancer Research (2004)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch.
Nature Genetics (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: